Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
enzalutamide - Google News
Get the latest updates from enzalutamide - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 7 hours ago
Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue ... - ScienceDirect.com
3 days ago
Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular...
Comparable Germline Variant Rates Seen Across Racial Groups in Metastatic Prostate Cancer - OncLive
6 days ago
Comparable Germline Variant Rates Seen Across Racial Groups in Metastatic Prostate Cancer...
Metastatic Prostate Cancer: Background and Patient Prognosis - Urology Times
7 days ago
Metastatic Prostate Cancer: Background and Patient Prognosis Urology Times
Astellas announced EC approval of Xtandi for expanded prostate cancer use - PMLiVE
7 days ago
Astellas announced EC approval of Xtandi for expanded prostate cancer use PMLiVE
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with ... - GlobeNewswire
8 days ago
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246...
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with ... - Yahoo Finance Australia
8 days ago
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246...
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with ... - Yahoo Finance
8 days ago
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246...
Enzalutamide Receives Go Ahead From European Commission in nmHSPC - OncLive
8 days ago
Enzalutamide Receives Go Ahead From European Commission in nmHSPC OncLive
Dr Townsend on the Genetic Evolutionary Trajectory of Prostate Cancer - OncLive
8 days ago
Dr Townsend on the Genetic Evolutionary Trajectory of Prostate Cancer OncLive
Enzalutamide granted approval in EU for nmHSPC - Urology Times
8 days ago
Enzalutamide granted approval in EU for nmHSPC Urology Times
Potential for Astellas' new prostate cancer drug with EC approval - OutSourcing-Pharma.com
8 days ago
Potential for Astellas' new prostate cancer drug with EC approval OutSourcing-Pharma.com
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early ... - The Malaysian Reserve
8 days ago
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent...